Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.1149 per EA under NDC 69584009450. Its NADAC has been published 281 times since Feb 10, 2021.
Strength
30 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584009450
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078302On Market Since
5/1/2020
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 281 times since Feb 10, 2021, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.2435 (Feb 10, 2021) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.1396 |
| Average price | $0.1516 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 281 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.1149 per EA (NDC 69584009450), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 52.8%. It has been tracked across 281 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Feb 10, 2021, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.2435 (Feb 10, 2021), with a median of $0.1396 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 69584009450) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification